期刊
SEMINARS IN CANCER BIOLOGY
卷 58, 期 -, 页码 100-108出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2019.01.003
关键词
YRNA; snRNA; snoRNA; lncRNA; piRNA; miRNA; circRNA; Biomarkers; Liquid biopsies; Non-coding RNA
类别
资金
- IKERBASQUE foundation for science
- Starmer-Smith memorial fund
- Ministerio de Economia y Competitividad (MINECO) of the Spanish Central Government
- FEDER funds [PIE13/00048, DTS14/00109, PI15/00275, PI18/01710]
- Departamento de Desarrollo EconOmico y Competitividad y Departamento de Sanidad of the Basque government
- Asociacion Espanola Contra el Cancer (AECC)
- Diputacion Foral de Guipuzcoa (DFG)
Non-invasive biomarkers or liquid biopsies have the potential to revolutionise cancer patient management as repeated sampling allows real-time monitoring of disease progression and response to treatment. This allows for earlier intervention and dynamic treatment management; both cornerstones of personalised medicine. The circulating transcriptome represents a rich source of potential cancer biomarkers that includes many classes of RNA, both coding and non-coding, that are only now beginning to be explored. In particular the increasing power and availability of RNAseq techniques have pushed studies beyond circulating miRNAs, to other classes of RNA including mRNA, snRNA, snoRNA, piRNA, YRNA, lncRNA and circRNA. In this review we focus on the emerging potential for these different classes of RNA as cancer biomarkers, and in particular the barriers and limitations that remain to be overcome if these molecules are to become part of routine clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据